View Older Stories View More Recent Stories

Jun 12, 2025 10:38AM UBS Reiterates Buy Rating on Eli Lilly (LLY)
Jun 10, 2025 03:25PM Citi on Hims and Hers (HIMS): 'If HIMS does end up partnering with LLY, in our view it would signal that HIMS is “throwing in the towel” on compounded GLP-1s'
Jun 10, 2025 06:42AM UBS Reiterates Buy Rating on Eli Lilly (LLY)
Jun 9, 2025 09:07AM UBS Reiterates Buy Rating on Eli Lilly (LLY)
Jun 6, 2025 07:02AM EMA says Ozempic, Wegovy may cause rare eye condition
Jun 5, 2025 09:12AM TD Cowen Revisits Eli Lilly's (LLY) Surpass-CVOT Expectations, Lowers Stock PT
Jun 5, 2025 04:52AM Erste Group Downgrades Eli Lilly (LLY) to Hold
Jun 4, 2025 05:00PM Morgan Stanley weighs in on Eli Lilly (LLY) into SURPASS-CVOT phrase 3 data
Jun 3, 2025 06:01AM Wegovy Use Up 50% Among Us Teens - Reuters
Jun 2, 2025 08:12AM Eli Lilly & Co. (LLY) presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer
May 29, 2025 05:01PM Eli Lilly & Co. (LLY) announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions
May 29, 2025 09:35AM UBS Reiterates Buy Rating on Eli Lilly (LLY)
May 28, 2025 09:41AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
May 27, 2025 10:00AM Eli Lilly & Co. (LLY) Acquires SiteOne Therapeutics
May 24, 2025 10:00PM What can get the U.S. large-cap pharma sector to work?
May 22, 2025 05:27PM Eli Lilly & Co. (LLY) gives presentation highlights for 2025 ASCO
May 22, 2025 09:35AM Morgan Stanley weighs in on Eli Lilly (LLY) following Cigna GLP-1 news
May 21, 2025 04:22PM Lilly (LLY) receives marketing authorization in Australia for the treatment of early symptomatic Alzheimer's disease
May 14, 2025 03:56PM Truist: 'we share some interesting takeaways from the ruling that could provide a read through on the Wegovy/Ozempic case'
May 14, 2025 08:20AM Bernstein: 'Softer Week for Total Scripts, but Eli Lilly (LLY) Still Gains Share'
May 13, 2025 10:08AM Bernstein Sees Eli Lilly (LLY) in 'Stronger Position Relative to Peers' Following Trump's Executive Order
May 12, 2025 10:11AM Trump discusses price gouging of 'fat drugs' in the U.S.
May 12, 2025 06:29AM Trump says drug prices to be cut by 59%
May 10, 2025 04:00PM These 2 sectors are under-owned, Barclays says and advises where to invest
May 9, 2025 08:00AM Eli Lilly & Co. (LLY) to expand Purdue University collaboration with up to a $250M investment to accelerate pharmaceutical innovation
May 8, 2025 06:46AM Eli Lilly & Co. (LLY) Announces Leaderhsip Changes
May 7, 2025 04:32PM Trump to pitch sweeping Medicare drug price plan - Politico
May 7, 2025 05:28AM Eli Lilly & Co. (LLY) option IV flat
May 5, 2025 12:48PM Eli Lilly & Co. (LLY) Declares $1.50 Quarterly Dividend; 0.7% Yield
May 5, 2025 12:00PM Hims & Hers is due to report after the bell on Monday. Here's what to expect
May 2, 2025 03:33PM Novo Nordisk shares jump as FDA accepts oral Wegovy application
May 2, 2025 11:53AM Eli Lilly (LLY) PT Lowered to $1,050 at UBS
May 2, 2025 10:17AM Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
May 2, 2025 09:33AM Eli Lilly (LLY) sell-off 'overdone' on CVS move on Wegovy - Leerink
May 1, 2025 06:49AM Eli Lilly & Co. (LLY) Misses Q1 EPS by 12c; updates guidance
May 1, 2025 04:00AM Eli Lilly faces Q1 sales headwinds as incretin gains offset by weakness in other drugs
Apr 30, 2025 10:27AM Eli Lilly & Co. (LLY) call put ratio 1 call to 1.2 puts into quarter results
Apr 30, 2025 05:53AM Eli Lilly & Co. (LLY) May 2 weekly 885 straddle priced into quarter results
Apr 29, 2025 11:21AM Eli Lilly & Co. (LLY) call put ratio 1.7 calls to 1 put into quarter results
Apr 29, 2025 08:41AM Hims & Hers shares surge over 40% on Wegovy pact with Novo Nordisk
Apr 28, 2025 02:12PM Eli Lilly & Co. (LLY) option implied volatility flat into quarter results
Apr 28, 2025 11:34AM HSBC cuts biotech stocks: Eli Lilly lowered to Reduce
Apr 28, 2025 06:22AM Goldman Sachs Reiterates Buy Rating on Eli Lilly (LLY)
Apr 28, 2025 03:24AM HSBC Downgrades Eli Lilly (LLY) to Reduce
Apr 22, 2025 08:11AM Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
Apr 22, 2025 08:04AM Bernstein on Eli Lilly (LLY): 'Our Top Pick Still Holds'
Apr 22, 2025 07:21AM Cantor Fitzgerald Starts Eli Lilly (LLY) at Overweight
Apr 21, 2025 10:58AM BMO Capital: 'Eli Lilly (LLY) Positions Orforglipron for a Global Launch'
Apr 17, 2025 03:12PM Eli Lilly & Co. (LLY) call put ratio 1.1 calls to 1 put as share price up 15.9%
Apr 17, 2025 10:57AM Eli Lilly (LLY) PT Lowered to $900 at BMO Capital
View More Recent Stories View Older Stories